Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
394.68 USD | +0.77% | +1.73% | +45.81% |
Projected Income Statement: HCA Healthcare, Inc.
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 51,336 | 51,533 | 58,752 | 60,233 | 64,968 | 70,831 | 74,777 | 78,682 |
Change | - | 0.38% | 14.01% | 2.52% | 7.86% | 9.03% | 5.57% | 5.22% |
EBITDA 1 | 9,857 | 10,037 | 12,644 | 12,067 | 12,726 | 14,041 | 14,791 | 15,604 |
Change | - | 1.83% | 25.97% | -4.56% | 5.46% | 10.34% | 5.34% | 5.5% |
EBIT 1 | 7,261 | 7,316 | 9,791 | 9,098 | 9,649 | 10,767 | 11,325 | 12,181 |
Change | - | 0.76% | 33.83% | -7.08% | 6.06% | 11.59% | 5.18% | 7.56% |
Interest Paid 1 | -1,824 | -1,584 | -1,566 | -1,741 | -1,938 | -2,069 | -2,152 | -2,230 |
Earnings before Tax (EBT) 1 | 5,244 | 5,430 | 9,833 | 8,580 | 7,706 | 8,871 | 9,205 | 9,781 |
Change | - | 3.55% | 81.09% | -12.74% | -10.19% | 15.12% | 3.76% | 6.26% |
Net income 1 | 3,505 | 3,754 | 6,956 | 5,643 | 5,242 | 5,957 | 6,278 | 6,715 |
Change | - | 7.1% | 85.3% | -18.88% | -7.11% | 13.63% | 5.4% | 6.96% |
Announcement Date | 28/01/20 | 02/02/21 | 27/01/22 | 27/01/23 | 30/01/24 | - | - | - |
Forecast Balance Sheet: HCA Healthcare, Inc.
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 33,101 | 29,211 | 33,128 | 37,176 | 38,658 | 40,360 | 40,732 | 41,138 |
Change | - | -11.75% | 13.41% | 12.22% | 3.99% | 4.4% | 0.92% | 1% |
Announcement Date | 28/01/20 | 02/02/21 | 27/01/22 | 27/01/23 | 30/01/24 | - | - | - |
Cash Flow Forecast: HCA Healthcare, Inc.
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
CAPEX 1 | 4,158 | 2,835 | 3,577 | 4,395 | 4,744 | 5,083 | 5,468 | 5,766 |
Change | - | -31.82% | 26.17% | 22.87% | 7.94% | 7.14% | 7.58% | 5.45% |
Free Cash Flow (FCF) 1 | 3,444 | 6,397 | 5,382 | 3,102 | 4,687 | 4,814 | 4,977 | 5,253 |
Change | - | 85.74% | -15.87% | -42.36% | 51.1% | 2.71% | 3.39% | 5.53% |
Announcement Date | 28/01/20 | 02/02/21 | 27/01/22 | 27/01/23 | 30/01/24 | - | - | - |
Forecast Financial Ratios: HCA Healthcare, Inc.
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
EBITDA Margin (%) | 19.2% | 19.48% | 21.52% | 20.03% | 19.59% | 19.82% | 19.78% | 19.83% |
EBIT Margin (%) | 14.14% | 14.2% | 16.66% | 15.1% | 14.85% | 15.2% | 15.14% | 15.48% |
EBT Margin (%) | 10.22% | 10.54% | 16.74% | 14.24% | 11.86% | 12.52% | 12.31% | 12.43% |
Net margin (%) | 6.83% | 7.28% | 11.84% | 9.37% | 8.07% | 8.41% | 8.4% | 8.53% |
FCF margin (%) | 6.71% | 12.41% | 9.16% | 5.15% | 7.21% | 6.8% | 6.66% | 6.68% |
FCF / Net Income (%) | 98.26% | 170.4% | 77.37% | 54.97% | 89.41% | 80.82% | 79.28% | 78.22% |
Profitability | ||||||||
ROA | 8.32% | 8.11% | 14.16% | 10.94% | 9.46% | 10.35% | 11.44% | 11.77% |
ROE | - | - | 352.48% | - | - | 182.96% | 148.29% | 78.75% |
Financial Health | ||||||||
Leverage (Debt/EBITDA) | 3.36x | 2.91x | 2.62x | 3.08x | 3.04x | 2.87x | 2.75x | 2.64x |
Debt / Free cash flow | 9.61x | 4.57x | 6.16x | 11.98x | 8.25x | 8.38x | 8.18x | 7.83x |
Capital Intensity | ||||||||
CAPEX / Current Assets (%) | 8.1% | 5.5% | 6.09% | 7.3% | 7.3% | 7.18% | 7.31% | 7.33% |
CAPEX / EBITDA (%) | 42.18% | 28.25% | 28.29% | 36.42% | 37.28% | 36.2% | 36.97% | 36.95% |
CAPEX / FCF (%) | 120.73% | 44.32% | 66.46% | 141.68% | 101.22% | 105.58% | 109.86% | 109.77% |
Items per share | ||||||||
Cash flow per share 1 | 21.83 | 26.87 | 27.25 | 28.92 | 34.12 | 36.61 | 37.49 | 42.21 |
Change | - | 23.07% | 1.43% | 6.13% | 17.97% | 7.29% | 2.42% | 12.59% |
Dividend per Share 1 | 1.63 | 0.43 | 1.92 | 2.24 | - | 2.633 | 2.753 | 2.869 |
Change | - | -73.62% | 346.51% | 16.67% | - | - | 4.57% | 4.19% |
Book Value Per Share 1 | -8.064 | 1.665 | -2.838 | -9.39 | - | -7.125 | -6.121 | -5.997 |
Change | - | -120.64% | -270.48% | 230.88% | - | - | -14.1% | -2.01% |
EPS 1 | 10.07 | 10.93 | 21.16 | 19.15 | 18.97 | 22.67 | 24.69 | 28.11 |
Change | - | 8.54% | 93.6% | -9.5% | -0.94% | 19.49% | 8.93% | 13.84% |
Nbr of stocks (in thousands) | 3,39,178 | 3,38,375 | 3,11,023 | 2,82,717 | 2,67,661 | 2,58,074 | 2,58,074 | 2,58,074 |
Announcement Date | 28/01/20 | 02/02/21 | 27/01/22 | 27/01/23 | 30/01/24 | - | - | - |
2024 * | 2025 * | |
---|---|---|
P/E ratio | 17.4x | 16x |
PBR | -55.4x | -64.5x |
EV / Sales | 2.01x | 1.91x |
Yield | 0.67% | 0.7% |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
- Stock Market
- Equities
- HCA Stock
- Financials HCA Healthcare, Inc.
MarketScreener is also available in this country: United States.
Switch edition